BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Pharmacology and Therapeutics

The World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal pharmacology and therapeutics.  It was launched on February 6, 2010 and is published irregularly by BPG, the world's leading professional clinical medical journal publishing company.

We encourage pharmacology and therapeutics specialists worldwide to submit manuscripts to the WJGPT describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGPT are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGPT’s acceptance rate: 49%.  Submit here >>

2019 Published Issues
  • Sin-Hyeog Im, PhD, Professor, (E-mail: iimsh@postech.ac.kr) Division of Integrative Biosciences and Biotechnology, Pohang University of Science & Technology, Pohang 37673, South Korea
  • Emanuele Sinagra, PhD, Attending Doctor, Doctor, (E-mail: emanuelesinagra83@googlemail.com) Gastroenterology and Endoscopy Unit, Fondazione Istituto Giuseppe Giglio, Cefalù 90015, Italy
WJGPT is now abstracted and indexed in PubMed, PubMed Central, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.
Journal Metrics
There is currently no impact factor.
2150-5349 (online)
Update on the management of gastrointestinal varices 
Umesha Boregowda, Chandraprakash Umapathy, Nasir Halim, Madhav Desai, Arpitha Nanjappa, Subramanyeswara Arekapudi, Thimmaiah Theethira, Helen Wong, Marina Roytman, Shreyas Saligram 
World J Gastrointest Pharmacol Ther 10(1):1-21. Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.1
Retrospective Study
Opioid use and misuse in ulcerative colitis 
Maithili V Chitnavis, Merwise Baray, Patrick G Northup, Anne G Tuskey, Brian W Behm 
World J Gastrointest Pharmacol Ther 10(1):22-28. Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.22
Case Report
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report 
Ammar B Nassri, Valery Muenyi, Ahmad AlKhasawneh, Bruno De Souza Ribeiro, James S Scolapio, Miguel Malespin, Silvio W de Melo Jr 
World J Gastrointest Pharmacol Ther 10(1):29-34. Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.29